Deepak Dsouza
Director Schizophrenia Neuropharmacology Research Group at Yale · Yale-New Haven Hospital
Credentials: · · ·
History
- Present
- Present
VA-CMHC Schizophrenia Research Clinic · Yale-New Haven Hospital
- Present
Yale Center for the Science of Cannabis and Cannabinoids · Yale-New Haven Hospital
1988–1992
Research
Neuropsychopharmacology · 2004 · First of 9 authors · Corresponding · 750 citations
Biological Psychiatry · 2005 · First of 9 authors · Corresponding · 446 citations
Review · Psychopharmacology · 2003 · 441 citations
70 papers
58 papers
- RR
34 papers · 13 as a resident
- RS
21 papers
- EP
20 papers · 2 as a resident
- IP
14 papers
12 papers
- DM
11 papers
Grants
- 2023–2028
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
National Institute on Drug Abuse · R01
Contact PI · $2.6M · Yale University
- 2024–2027
Acute Effects of THC in Older Adults
National Institute on Drug Abuse · R21
Contact PI · $460.6K · Yale University
- 2022–2027
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.
Department of Veterans Affairs · I01
Contact PI · Va Connecticut Healthcare System
- 2023–2026
The Potential Therapeutic Effects of N, N-Dimethyltryptamine (DMT) on Alcohol Use Disorder (AUD)
National Institute on Alcohol Abuse and Alcoholism · R21
PI · $343.6K · Yale University
Clinical trials
- 2025–2027
- 2025–2027
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
Principal investigator · Recruiting · Phase 1
Deepak C. D'Souza
- 2024–2028
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Principal investigator · Recruiting · Phase 1
Yale University
- 2023–2029
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
Principal investigator · Recruiting · Phase 2
VA Office of Research and Development